Drug development

Bioinformatics can be used to study genetic variations that influence drug response in individuals. By analysing genomic data, we can identify genetic markers that can predict how an individual might respond to a particular drug or their susceptibility to adverse drug reactions.

In pharmacology, bioinformatics is used in various areas such as drug target identification and validation. It is also used in the development of biomarkers and toxicogenomic and pharmacogenomic tools to maximise the therapeutic benefit of drugs.

Drug target identification includes analysis of gene sequences, protein structures, protein-protein interactions, and metabolic pathways. 

The role of bioinformatics in drug development 

Bioinformatic analysis can accelerate drug target identification and can  facilitate characterization of side effects and predict drug resistance.

Some of the specific applications include gene sequencing, genetic statistics, and the measurement of gene expression levels. 

Our company’s bioinformatics applications include sequence analysis, molecular modelling, molecular dynamics using programming languages, machine learning algorithms and a combination of bioinformatics tools that are part of a broader landscape of bioinformatics tools to integrate and analyze diverse data types, facilitating the discovery and development of new therapeutic agents.
 

At KonAnBio we can extract, analyse, and communicate hidden information from sequences and structures, in order to discover and identify new drug targets.